{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:45:06Z","timestamp":1787013906096,"version":"build-2736575974"},"reference-count":37,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Tacrolimus is an immunosuppressant largely used in heart transplantation. However, the calculation of its exposure based on the area under the curve (AUC) requires the use of a population pharmacokinetic (PK) model. The aims of this work were (i) to develop a population PK model for tacrolimus in heart transplant patients, (ii) to derive a maximum a posteriori Bayesian estimator (MAP\u2010BE) based on a limited sampling strategy (LSS) and (iii) to estimate probabilities of target attainment (PTAs) for AUC and trough concentration (C0).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Methods<\/jats:title>\n                    <jats:p>Forty\u2010seven PK profiles (546 concentrations) of 18 heart transplant patients of the Pharmacocin\u00e9tique des Immunosuppresseurs chez les patients GREff\u00e9s Cardiaques study receiving tacrolimus (Prograf\u00ae) were included. The database was split into a development (80%) and a validation (20%) set. PK parameters were estimated in MONOLIX\u00ae and based on this model a Bayesian estimator using an LSS was built. Simulations were performed to calculate the PTA for AUC and C0.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The best model to describe the tacrolimus PK was a two\u2010compartment model with a transit absorption and a linear elimination. Only the CYP3A5 covariate was kept in the final model. The derived MAP\u2010BE based on the LSS (0\u20101\u20102\u00a0h postdose) yielded an AUC bias\u2009\u00b1\u2009SD\u2009=\u00a02.7\u2009\u00b1\u00a010.2% and an imprecision of 9.9% in comparison to the reference AUC calculated using the trapezoidal rule. PTAs based on AUC or C0 allowed new recommendations to be proposed for starting doses (0.11\u2009mg\u00b7kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      \u00b712\u2009h\n                      <jats:sup>\u22121<\/jats:sup>\n                      for the CYP3A5 nonexpressor and 0.22\u2009mg\u00b7kg\n                      <jats:sup>1<\/jats:sup>\n                      \u00b712\u2009h\n                      <jats:sup>\u22121<\/jats:sup>\n                      for the CYP3A5 expressor).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The MAP\u2010BE developed should facilitate estimation of tacrolimus AUC in heart transplant patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bcp.15857","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T05:08:23Z","timestamp":1689916103000},"page":"3584-3595","source":"Crossref","is-referenced-by-count":11,"title":["Tacrolimus population pharmacokinetics in adult heart transplant patients"],"prefix":"10.1111","volume":"89","author":[{"given":"Adrien","family":"Paschier","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Toxicology and Pharmacovigilance University Hospital of Limoges  Limoges France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Destere","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology University Hospital of Nice  Nice France"},{"name":"Pharmacology &amp; Transplantation, INSERM U1248 Universit\u00e9 de Limoges  Limoges France"},{"name":"Universit\u00e9 C\u00f4te d'Azur, Inria, CNRS, Laboratoire J.A. Dieudonn\u00e9, Maasai team  Nice France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Monchaud","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Pharmacovigilance University Hospital of Limoges  Limoges France"},{"name":"Pharmacology &amp; Transplantation, INSERM U1248 Universit\u00e9 de Limoges  Limoges France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5840-8904","authenticated-orcid":false,"given":"Marc","family":"Labriffe","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Pharmacovigilance University Hospital of Limoges  Limoges France"},{"name":"Pharmacology &amp; Transplantation, INSERM U1248 Universit\u00e9 de Limoges  Limoges France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Marquet","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Pharmacovigilance University Hospital of Limoges  Limoges France"},{"name":"Pharmacology &amp; Transplantation, INSERM U1248 Universit\u00e9 de Limoges  Limoges France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1695-0695","authenticated-orcid":false,"given":"Jean\u2010Baptiste","family":"Woillard","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Pharmacovigilance University Hospital of Limoges  Limoges France"},{"name":"Pharmacology &amp; Transplantation, INSERM U1248 Universit\u00e9 de Limoges  Limoges France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15566"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm\u20102018\u2010001764"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs\u20102018\u20100116"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600\u20106143.2006.01290.x"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000640"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2021.100610"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0041\u20101345(02)03097\u2010x"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13318\u2010017\u20100453\u20107"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00358"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.3109\/03602532.2016.1151037"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262\u2010019\u201000854\u20101"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13952"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13318\u2010019\u201000591\u20107"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v074.i07"},{"key":"e_1_2_11_16_1","unstructured":"Monolix version 2023R1. Anthony France: Lixoft SAS 2023. Accessed July 8 2022.https:\/\/lixoft.com\/products\/monolix\/"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14261"},{"key":"e_1_2_11_18_1","unstructured":"Simulx version 2023R1. Anthony France: Lixoft SAS 2023. Accessed July 8 2022.https:\/\/lixoft.com\/products\/simulx\/"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e318285e779"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1121"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14752"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14753"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102125.2010.03837.x"},{"key":"e_1_2_11_24_1","unstructured":"Population totale par sexe et \u00e2ge au 1er janvier 2020 France m\u00e9tropolitaine \u2212 Bilan d\u00e9mographique 2019|Insee. Accessed July 15 2022.https:\/\/www.insee.fr\/fr\/statistiques\/1892088?sommaire=1912926"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.2165\/11594760\u2010000000000\u201000000"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.4103\/1319\u20102442.318511"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13838"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13960"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262\u2010020\u201000959\u2010y"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13595"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262\u2010016\u20100396\u20101"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000134"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2014.110"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12649"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/86882"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009\u20109236(03)00168\u20101"},{"key":"e_1_2_11_37_1","unstructured":"R\u00e9sum\u00e9 des Caract\u00e9ristiques du Produit. Accessed July 26 2022.http:\/\/agence-prd.ansm.sante.fr\/php\/ecodex\/rcp\/R0235253.htm"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12507"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.15857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T03:03:14Z","timestamp":1702090994000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.15857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1111\/bcp.15857"],"URL":"https:\/\/doi.org\/10.1111\/bcp.15857","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,10]]}}}